Malaria is a mosquito-borne disease caused by Plasmodium parasites that are transmitted via the bites of infected Anopheles mosquitoes. The parasites multiply within the liver and red blood cells. Symptoms include fever, chills, and flu-like illness. Malaria is diagnosed by examining blood smears under a microscope and can be confirmed by abnormal blood test results. Treatment depends on the Plasmodium species, but involves antimalarial medications like chloroquine, primaquine, artemether, or combinations of drugs. Prevention involves awareness, avoiding mosquito bites, antimalarial medications for high-risk areas, and prompt treatment of infections.
Malaria is an infectious disease that is caused by mosquito-borne plasmodium parasite which infects the red blood cells. It’s one of the deadliest diseases in India. There’s no vaccine for malaria yet and immunity occurs naturally through repeated infection. Common symptoms are fever, chills, vomiting, nausea, body ache, headache, cough and diarrhea. If untreated, it can lead to complications like jaundice, dehydration, anemia, brain malaria, liver failure and kidney failure. To know more visit here: www.lazoi.com
Malaria is an infectious disease that is caused by mosquito-borne plasmodium parasite which infects the red blood cells. It’s one of the deadliest diseases in India. There’s no vaccine for malaria yet and immunity occurs naturally through repeated infection. Common symptoms are fever, chills, vomiting, nausea, body ache, headache, cough and diarrhea. If untreated, it can lead to complications like jaundice, dehydration, anemia, brain malaria, liver failure and kidney failure. To know more visit here: www.lazoi.com
Malaria -causes| types| management -medical information martinshaji
this is a brief study on disease malaria, mentioning all aspects in detail which can provide you a good idea about the management of the disease and clinical watching
please comment
thank you
This presentation includes definition, epidemiology, etiology, pathophysiology (life cycle), diagnosis, clinical features of uncomplicated & severe malaria and treatment of malaria.
Malaria -causes| types| management -medical information martinshaji
this is a brief study on disease malaria, mentioning all aspects in detail which can provide you a good idea about the management of the disease and clinical watching
please comment
thank you
This presentation includes definition, epidemiology, etiology, pathophysiology (life cycle), diagnosis, clinical features of uncomplicated & severe malaria and treatment of malaria.
Natural compounds from the bark of the cinchona tree, most notably quinine was observed to exhibit antimalarial activity.
Until the development of synthetic derivatives (ie. 4-aminoquinoline antimalarials), quinine continued to be the first choice to treat malaria.
Quinine is associated with side effects such as diarrhœa.
4-aminoquinoline antimalarials such as amodiaquine and chloroquine largely replaced quinine because of reduced unpleasant side effects.
The life cycle of the parasite and the immunological defence mechanisms against the parasite are complex.
Part of the parasite’s life cycle involves invasion of red blood cells (erythrocytes).
The haemoglobin within the red blood cell is broken down by the parasite and is used as a source of amino acids.
The 4-aminoquinolines act at the erythrocytic stage of the parasite.
Doxycycline is a compound used in prophylaxis against plasmodial parasites.
Other compounds associated with treating malaria include halofantrine and lumefantrine, often used in combination with other drugs.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
2. • Malaria is a mosquito-borne infectious
disease of humans and other animals.
• Its a disease of the blood that is caused by the
Plasmodium parasite
• Transmitted from person
to person by a particular type of mosquito.
3. • The term malaria originates
from Medieval Italian: mala aria — "bad air";
• in 1880, Charles Louis Alphonse Laveran made a
scientific studies and observed parasites inside
the red blood cells.
• In April 1894, a Scottish physician Sir Ronald Ross
proved that the mosquito was the vector for
malaria in humans.
• He isolated malaria parasites from the salivary
glands of mosquitoes.
4. • Malaria is caused by a parasite that is passed
from one human to another by the bite of
infected Anopheles mosquitoes.
• Malaria parasites belong to the
genus Plasmodium (phylum Apicomplexa).
• malaria is caused by P. falciparum
(75%), P. malariae, P. ovale, P. vivax(20%) and
P. knowlesi.
5.
6. • Malaria is usually diagnosed by the
microscopic examination of blood films or
by antigen-based rapid diagnostic tests (RDT).
• Confirmed by low number of platelets in the
blood, and higher-than-normal levels of
bilirubin in the blood combined with a normal
level of white blood cells.
7. • Malaria is treated with oral chloroquine
except malaria caused by P. falciparum.
• Malaria caused by P. falciparum requires
treatment with oral quinine, given
concurrently with pyrimethamine with
sulfodoxine and a sulfonamide, such as
sulfadiazine.
• For the hepatic stage of disease: primaquine
phosphate, given daily for 14 days.
8. • Artemether is a potent and quick acting
antimalarial agent, used for treating
chloroquine resistant falciparum malaria,
including cerebral malaria.
• Proguanil is an antiprotozoal and antimalarial,
prescribed for prevention of malaria,
treatment of malaria. It prevents the
development of malaria parasites.
11. There is an ABCD for prevention of malaria.
This is:
Awareness of risk of malaria.
Bite prevention.
Antimalarial medication - Chemoprophylaxis
(taking antimalarial medication exactly as
prescribed).
Prompt Diagnosis and treatment.